Table 4. Combinations of antipsychotics and hyperprolactinemia.
| Combinations of antipsychotics (N = 58) | N (%) | Hyperprolactinemia (%) |
|---|---|---|
| amisulpride + haloperidol | 1 (1.7%) | 1 (100%) |
| haloperidol + levomepromazine | 7 (12.1%) | 7 (100%) |
| aripiprazole + haloperidol | 3 (5.2%) | 2 (66.7%) |
| aripiprazole + levomepromazine | 1 (1.7%) | 1 (100%) |
| olanzapine + amisulpride | 1 (1.7%) | 1 (100%) |
| olanzapine + flupenthixol | 1 (1.7%) | 0 |
| olanzapine + haloperidol | 8 (13.8%) | 6 (75%) |
| olanzapine + haloperidol + levomepromazine | 4 (6.9%) | 4 (100%) |
| olanzapine + levomepromazine | 1 (1.7%) | 0 |
| quetiapine + haloperidol | 14 (24.2%) | 9 (64.3%) |
| quetiapine + haloperidol + levomepromazine | 2 (3.5%) | 2 (100%) |
| quetiapine + levomepromazine | 12 (20.7%) | 7 (58.3%) |
| risperidone + haloperidol + levomepromazine | 1 (1.7%) | 1 (100%) |
| risperidone + levomepromazine | 1 (1.7%) | 1 (100%) |
| ziprasidone + levomepromazine | 1 (1.7%) | 1 (100%) |
N–number of patients.